Table 3 Summary of patient characteristics by BART parameters
FMD% | PFV% | |||||||
|---|---|---|---|---|---|---|---|---|
Characteristics | N | Mean ± SD | Median (Range) | p-value* | N | Mean ± SD | Median (Range) | p-value* |
Age | ||||||||
<60 | 15 | 12.8 ± 9.0 | 12.5 (0, 38.1) | 0.795 | 15 | 103.1 ± 64.2 | 90 (10, 291) | 0.243 |
>60 | 11 | 11.9 ± 9.5 | 11.1 (0, 29.7) | 11 | 78.0 ± 50.6 | 81 (21, 175) | ||
Sex | ||||||||
Male | 17 | 11.3 ± 7.4 | 11.1 (0, 29.7) | 0.418 | 17 | 102.0 ± 65.3 | 90 (10, 291) | 0.346 |
Female | 9 | 14.6 ± 11.6 | 14.8 (0, 38.1) | 9 | 74.4 ± 42.6 | 60 (21, 139) | ||
Smoker | ||||||||
No | 9 | 11.0 ± 11.9 | 10.3 (0, 38.1) | 0.293 | 9 | 82.9 ± 46.9 | 96 (10, 139) | 0.979 |
Yes | 17 | 13.2 ± 7.4 | 14.3 (0, 29.7) | 17 | 97.5 ± 65.4 | 85 (21, 291) | ||
Length of stay | ||||||||
<5 | 12 | 12.9 ± 8.2 | 12.2 (0, 29.7) | 0.554 | 12 | 76.9 ± 40.1 | 83.5 (21, 139) | 0.304 |
>5 | 14 | 12.0 ± 9.9 | 10.45 (0, 38.1) | 14 | 105.8 ± 70.2 | 93.5 (10, 291) | ||
Obesity | ||||||||
No | 16 | 12.9 ± 10.2 | 11.5 (0, 38.1) | 0.958 | 16 | 87.6 ± 38.1 | 88.5 (10, 145) | 1.00 |
Yes | 10 | 11.7 ± 7.3 | 12.3 (0, 22.2) | 10 | 100.3 ± 84.6 | 76 (21, 291) | ||
Chemotherapy | ||||||||
No | 13 | 15.8 ± 9.3 | 11.9 (6.2, 38.1) | 0.117 | 13 | 75.0 ± 40.2 | 85 (10, 139) | 0.191 |
Yes | 13 | 9.1 ± 7.7 | 8.9 (0, 20.5) | 13 | 109.9 ± 70.6 | 98 (30, 291) | ||
Radiotherapy | ||||||||
No | 15 | 15.4 ± 9.5 | 12.5 (0, 38.1) | 0.058 | 15 | 78.4 ± 46.4 | 85 (10, 175) | 0.243 |
Yes | 11 | 8.4 ± 6.8 | 8.9 (0, 18.9) | 11 | 111.6 ± 70.7 | 98 (30, 291) | ||
ASA Score | ||||||||
2 | 2 | 11.4 ± 7.4 | 11.45 (6.2, 16.7) | ** | 2 | 29.5 ± 27.6 | 29.5 (10, 49) | ** |
3 | 24 | 12.5 ± 9.3 | 11.5 (0, 38.1) | 24 | 97.7 ± 58.2 | 89.5 (21, 291) | ||
Lee Cardiac Risk Index | ||||||||
2 | 25 | 12.7 ± 9.1 | 11.9 (0, 38.1) | ** | 25 | 95.8 ± 57.8 | 89 (21, 291) | ** |
3 | 1 | 6.2 ± NA | 6.2 (6.2, 6.2) | 1 | 10.0 ± NA | 10 (10, 10) | ||
ACC/AHA Risk Score | ||||||||
≤2 | 23 | 12.6 ± 9.3 | 11.9 (0, 38.1) | ** | 23 | 94.1 ± 57.2 | 89 (21, 291) | ** |
>2 | 2 | 6.8 ± 0.9 | 6.85 (6.2, 7.5) | 2 | 32.0 ± 31.1 | 32 (10, 54) | ||
Diabetes Mellitus | ||||||||
No | 23 | 12.4 ± 9.4 | 11.9 (0, 38.1) | ** | 23 | 91.4 ± 57.6 | 88 (21, 291) | ** |
Yes | 3 | 12.3 ± 7.4 | 10.3 (6.2, 20.5) | 3 | 100.3 ± 83.6 | 116 (10, 175) | ||
Hypertension | ||||||||
No | 12 | 16.1 ± 9.1 | 13.4 (7.5, 38.1) | 0.089 | 12 | 90.0 ± 33.9 | 89 (26, 145) | 0.719 |
Yes | 14 | 9.3 ± 8.0 | 8.25 (0, 22.2) | 14 | 94.6 ± 75.6 | 85.5 (10, 291) | ||
Hyperlipidemia | ||||||||
No | 17 | 15.6 ± 9.0 | 14.8 (2.3, 38.1) | 0.006 | 17 | 90.4 ± 45.8 | 89 (21, 175) | 0.571 |
Yes | 9 | 6.4 ± 5.5 | 6.2 (0, 14.3) | 9 | 96.4 ± 81.7 | 82 (10, 291) | ||
Statin Therapy | ||||||||
No | 20 | 13.8 ± 9.6 | 13.4 (0, 38.1) | 0.120 | 20 | 90.7 ± 44.0 | 89.5 (21, 175) | 0.429 |
Yes | 6 | 7.9 ± 5.2 | 8 (0, 14.3) | 6 | 98.3 ± 100.2 | 81.5 (10, 291) | ||
ACE-Inhibitor Therapy | ||||||||
No | 23 | 13.2 ± 9.3 | 12.5 (0, 38.1) | ** | 23 | 93.4 ± 59.7 | 88 (21, 291) | ** |
Yes | 3 | 6.5 ± 3.7 | 6.2 (3, 10.3) | 3 | 85.0 ± 65.3 | 116 (10, 129) | ||
AT2-Inhibitor Therapy | ||||||||
No | 25 | 12.2 ± 9.2 | 11.1 (0, 38.1) | ** | 25 | 94.2 ± 59.6 | 89 (10, 291) | ** |
Yes | 1 | 16.7 ± NA | 16.7 (16.7, 16.7) | 1 | 49.0 ± NA | 49 (49, 49) | ||
Beta-Blocker Therapy | ||||||||
No | 20 | 12.9 ± 9.8 | 12.2 (0, 38.1) | 0.670 | 20 | 94.0 ± 61.3 | 89.5 (21, 291) | 0.808 |
Yes | 6 | 10.9 ± 6.1 | 8.9 (5.1, 20.5) | 6 | 87.5 ± 55.9 | 85 (10, 175) | ||